Cidara Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 02/14/2025 | 1.09 M | $29.37 M | 55.43% | 17.21% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 1.09 M | $29.37 M | 55.43% | 17.21% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 1.01 M | $26.09 M | 100.00% | 15.84% |
| VR ADVISER, LLC | 02/14/2025 | 765,723 | $20.58 M | 100.00% | 12.06% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/14/2025 | 703,080 | $18.90 M | 0.00% | 11.07% |
| VIVO CAPITAL, LLC | 02/13/2025 | 670,600 | $18.03 M | 100.00% | 10.56% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 369,954 | $9.94 M | 765.29% | 5.83% |
| CHECKPOINT CAPITAL L.P. | 02/14/2025 | 196,949 | $5.11 M | 7.96% | 3.10% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 95,617 | $2.57 M | -2.25% | 1.51% |
| 5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 56,725 | $1.52 M | 0.00% | 0.89% |
| BLACKROCK, INC. | 02/07/2025 | 55,525 | $1.49 M | 13.50% | 0.87% |
| ACUTA CAPITAL PARTNERS, LLC | 02/14/2025 | 54,473 | $1.46 M | 100.00% | 0.86% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 53,940 | $1.45 M | 100.00% | 0.85% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 53,068 | $1.43 M | 0.32% | 0.84% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 49,557 | $1.33 M | 154.14% | 0.78% |
| STEMPOINT CAPITAL LP | 02/14/2025 | 47,642 | $1.28 M | 100.00% | 0.75% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 42,623 | $1.15 M | 100.00% | 0.67% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 35,960 | $966,605 | 158.35% | 0.57% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 24,938 | $670,333 | 100.00% | 0.39% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 15,601 | $419,355 | 100.00% | 0.25% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 02/14/2025 | 14,311 | $384,680 | -82.09% | 0.23% |
| OMERS ADMINISTRATION CORP | 02/14/2025 | 12,600 | $338,688 | 100.00% | 0.20% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 6,148 | $165,245 | 100.00% | 0.10% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 2,085 | $56,050 | 100.00% | 0.03% |
| MANCHESTER CAPITAL MANAGEMENT LLC | 01/30/2025 | 470 | $12,634 | 0.00% | 0.01% |
| AVION WEALTH | 01/29/2025 | 250 | $6,000 | 0.00% | 0.00% |
| POINT72 (DIFC) LTD | 02/14/2025 | 198 | $5,330 | 100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 01/30/2025 | 40 | $880 | 0.00% | 0.00% |
| 02/06/2025 | 20 | $538 | 100.00% | 0.00% | |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| MONASHEE INVESTMENT MANAGEMENT LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| PACIFICA PARTNERS INC. | 01/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cidara Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 40 institutional investors and hedge funds held shares of Cidara Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 1.09 M
BVF INC/IL: 1.09 M
TCG Crossover Management, LLC: 1.01 M
VR Adviser, LLC: 765,723
Bain Capital Life Sciences Investors, LLC: 703,080
Vivo Capital, LLC: 670,600
107.95% of Cidara Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 10.72 M shares in the last 24 months. This purchase volume represents approximately $205.82 M in transactions.